ARTV

COM:ARTIVABIO

Artiva Biotherapeutics

Stock

Last Close

10.88

22/11 21:00

Market Cap

105.10M

Beta: -

Volume Today

36.36K

Avg: -

Overview Analysis Metrics Financials Filings people API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Mar '23	Jun '23	Sep '23	Dec '23	Mar '24	Jun '24	Sep '24
net income	-16.72M -	-11.28M 32.50%	11.28M 199.96%	-12.00M 206.37%	-13.96M 16.38%	-17.84M 27.79%	-17.47M 2.08%
depreciation and amortization	578K -	538K 6.92%	556K 3.35%	594K 6.83%	587K 1.18%	603K 2.73%	627K 3.98%
deferred income tax
stock based compensation	1.83M -	2.46M 34.17%	1.37M 44.22%	1.39M 1.53%	1.41M 1.01%	1.48M 5.48%	1.91M 28.59%
change in working capital	64K -	-3.46M 5,509.38%	-23.80M 587.32%	-1.09M 95.43%	-3.02M 177.46%	-7K 99.77%	3.01M 43,085.71%
accounts receivables	-548K -	-1.14M 108.76%	-579K 49.39%	1.72M 396.37%	215K 87.47%	250K 16.28%	760K 204%
inventory
accounts payables	520K -	-592K 213.85%	1.59M 367.91%	-1.92M 221.19%	851K 144.28%	-954K 212.10%	704K 173.79%
other working capital	388K -	-1.78M 558.76%	-24.80M 1,293.37%	-881K 96.45%	45K 105.11%	85K 88.89%	1.54M 1,717.65%
other non cash items			-159K -	424K 366.67%			318K -
net cash provided by operating activities	-14.24M -	-11.76M 17.41%	-10.75M 8.64%	-10.68M 0.68%	-15.09M 41.32%	-13.69M 9.29%	-11.61M 15.16%
investments in property plant and equipment	-1.86M -	-581K 68.80%	-179K 69.19%	-636K 255.31%	-18K 97.17%	-464K 2,477.78%	-96K 79.31%
acquisitions net
purchases of investments		-22.37M -	-12.31M 44.96%	-14.83M 20.45%	-6.20M 58.20%	-12.19M 96.56%	-142.93M 1,072.82%
sales maturities of investments		2M -	12M 500%	12.80M 6.67%	16M 25%	14M 12.50%	12.40M 11.43%
other investing activites
net cash used for investing activites	-1.86M -	-20.95M 1,025.24%	-493K 97.65%	-2.67M 441.18%	9.78M 466.64%	1.35M 86.21%	-130.63M 9,783.32%
debt repayment							-38K -
common stock issued
common stock repurchased	-12K -
dividends paid
other financing activites			23.43M -	962K 95.89%			-2.60M -
net cash used provided by financing activities	-12K -	10K 183.33%	23.43M 234,210%	962K 95.89%		-1.62M -	163.87M 10,240.59%
effect of forex changes on cash
net change in cash	-16.12M -	-32.71M 102.93%	12.19M 137.27%	-12.38M 201.57%	-5.30M 57.16%	-13.95M 163.05%	21.63M 255.05%
cash at beginning of period	102.78M -	86.66M 15.68%	53.95M 37.74%	66.14M 22.59%	53.76M 18.72%	48.46M 9.87%	34.51M 28.79%
cash at end of period	86.66M -	53.95M 37.74%	66.14M 22.59%	53.76M 18.72%	48.46M 9.87%	34.51M 28.79%	56.14M 62.69%
operating cash flow	-14.24M -	-11.76M 17.41%	-10.75M 8.64%	-10.68M 0.68%	-15.09M 41.32%	-13.69M 9.29%	-11.61M 15.16%
capital expenditure	-1.86M -	-581K 68.80%	-179K 69.19%	-636K 255.31%	-18K 97.17%	-464K 2,477.78%	-96K 79.31%
free cash flow	-16.11M -	-12.35M 23.35%	-10.93M 11.49%	-11.31M 3.51%	-15.10M 33.53%	-14.15M 6.32%	-11.71M 17.26%

All numbers in (except ratios and percentages)